VIDEX 10 mg in 1 mL (final concentration) Powder for Oral Solution
RxNorm 542059
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 542059 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: VIDEX 10 mg in 1 mL (final concentration) Powder for Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
DdI 10 mg/ML Oral Solution [Videx]
(Atom ID: 8699099)
SBD
Semantic Branded Drug (SBD):
Didanosine 10 mg/ML Oral Solution [Videx]
(Atom ID: 12371742)
SY
Synonym (SY):
Dideoxyinosine 10 mg/ML Oral Solution [Videx]
(Atom ID: 8699101)
PSN
Prescribable Name (PSN):
VIDEX 10 mg in 1 mL (final concentration) Powder for Oral Solution
(Atom ID: 8725203)
SY
Synonym (SY):
Videx 10 mg per 1 mL Powder for Oral Solution
(Atom ID: 8725204)
SY
Synonym (SY):
Videx 10 mg/ML final mix (20 mg/ML initial mix) Oral Solution
(Atom ID: 2985191)
Patient Education
Didanosine
Didanosine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Didanosine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood. Although didanosine does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
[Learn More]
* Please review the disclaimer below.